Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma

被引:60
作者
Kasperts, N
Slotman, BJ
Leemans, CR
de Bree, R
Doornaert, P
Langendijk, JA
机构
[1] Univ Groningen, Med Ctr, Dept Radiat Oncol, NL-9300 RB Groningen, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
关键词
locoregional control; postoperative reirradiation; quality of life; second primary tumors; survival; toxicity;
D O I
10.1002/cncr.21768
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. In this prospective study, the effects of a second course of postoperative radiation therapy on locoregional control, survival, toxicity, and quality of life were investigated in patients who underwent resection of a second primary or locoregional recurrent head and neck tumor in a previously irradiated area. METHODS. in total, 39 patients who underwent surgery for second primary tumors (n = 19 patients) or for recurrent locoregional tumors (n = 20 patients) were retreated with postoperative radiotherapy (RE-PORT). Indications for RE-PORT were extranodal spread (49%), positive surgical margins (44%), and/or other risk factors (8%). The target Volume for RE-PORT was confined to the high-risk area. No elective radiotherapy was applied in regions that were Situated in the formerly high-dose area. A total dose of 46 grays (Gy) was given to elective areas with boosts front 60 Gy to 66 Gy to the high-risk region with conventional fractionation. The results of RE-PORT were compared with the results front patients who were treated in the same period with primary adjuvant radiotherapy (PRI-PORT) at the authors' institution. RESULTS. The mean follow-tip was 32 months (range, 3-84 mos). The locoregional control rate after 3 years in the RE-PORT group was 74%, and the 3-year overall Survival rate was 44%. This did not differ significantly compared with survival rates in the PRI-PORT group. Although a higher rate of late radiation-induced morbility and more head and neck symptoms were observed in the RE-PORT group compared with the PRI-PORT group, no differences were observed with regard to the more general dimensions of quality of life. CONCLUSIONS. RE-PORT after surgery for recurrent locoregional tumors and/or second primary tumors should be considered in patients who have high-risk histopathologic features.
引用
收藏
页码:1536 / 1547
页数:12
相关论文
共 26 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation [J].
Awwad, HK ;
Lotayef, M ;
Shouman, T ;
Begg, AC ;
Wilson, G ;
Bentzen, SM ;
Abd El-Moneim, H ;
Eissa, S .
BRITISH JOURNAL OF CANCER, 2002, 86 (04) :517-523
[3]  
BARTELINK H, 1983, CANCER-AM CANCER SOC, V52, P1008, DOI 10.1002/1097-0142(19830915)52:6<1008::AID-CNCR2820520613>3.0.CO
[4]  
2-B
[5]   Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer [J].
Bernier, J ;
Domenge, C ;
Ozsahin, M ;
Matuszewska, K ;
Lefèbvre, JL ;
Greiner, RH ;
Giralt, J ;
Maingon, P ;
Rolland, F ;
Bolla, M ;
Cognetti, F ;
Bourhis, J ;
Kirkpatrick, A ;
van Glabbeke, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1945-1952
[6]   DEVELOPMENT OF A EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) QUESTIONNAIRE MODULE TO BE USED IN QUALITY-OF-LIFE ASSESSMENTS IN HEAD AND NECK-CANCER PATIENTS [J].
BJORDAL, K ;
AHLNERELMQVIST, M ;
TOLLESSON, E ;
JENSEN, AB ;
RAZAVI, D ;
MAHER, EJ ;
KAASA, S .
ACTA ONCOLOGICA, 1994, 33 (08) :879-885
[7]   THE VALUE OF FOLLOW-UP IN PATIENTS TREATED FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
BOYSEN, M ;
LOVDAL, O ;
TAUSJO, J ;
WINTHER, F .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :426-430
[8]   RADICAL NECK DISSECTIONS FOR SQUAMOUS CARCINOMAS - PATHOLOGICAL FINDINGS AND THEIR CLINICAL IMPLICATIONS WITH PARTICULAR REFERENCE TO TRANSCAPSULAR SPREAD [J].
CARTER, RL ;
BLISS, JM ;
SOO, KC ;
OBRIEN, CJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (06) :825-832
[9]   THE CLINICAL-SIGNIFICANCE OF PATHOLOGICAL FINDINGS IN SURGICALLY RESECTED MARGINS OF THE PRIMARY TUMOR IN HEAD AND NECK-CARCINOMA [J].
CHEN, TY ;
EMRICH, LJ ;
DRISCOLL, DL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (06) :833-837
[10]   Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck [J].
Cooper, JS ;
Pajak, TF ;
Forastiere, AA ;
Jacobs, J ;
Campbell, BH ;
Saxman, SB ;
Kish, JA ;
Kim, HE ;
Cmelak, AJ ;
Rotman, M ;
Machtay, M ;
Ensley, JF ;
Chao, KSC ;
Schultz, CJ ;
Lee, N ;
Fu, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1937-1944